Seattle Genetics Gets $12 Million In Astellas Deal
Seattle Genetics receives $12 million in expansion of partnership with Astellas
11:12AM 11/23/09
'Mad Money Lightning Round': Stick With Goldman Sachs
Cramer says investors should hold onto the stock for the long term.
07:15PM 11/04/09
Cramer's 'Mad Money' Recap: The Bears' Negative Script (Final)
Cramer says the bears' pessimistic message has cost investors a fortune in the market. Click for news from Jim Cramer.
06:28PM 11/04/09
Seattle Genetics 3Q Loss Narrows On Partnerships
Seattle Genetics' 3rd-quarter loss narrows on higher revenue from partnerships
06:18PM 10/22/09
Investors Eye Vertex Hep C Competitor: BioBuzz
Is there a Hep C drug which can knock off Vertex's telaprevir?
11:04AM 10/05/09
Seattle Genetics Halts Lymphoma Drug Study
Seattle Genetics ends mid-stage lymphoma trial, says results unlikely to meet goals
08:26AM 10/05/09
Seattle Genetics Halts Lymphoma Drug Study: BioBuzz
Drug deemed futile by independent data monitors, other trials continue
07:37AM 10/05/09
'Fast Money' Portfolios of the Week
Here's what the 'Fast Money' crew has been talking about lately.
07:00AM 10/01/09
'Fast Money' Recap: Adding Abbott
A trader says Abbott is a stock you have to own in your portfolio. He sees it going north of $50.
07:21PM 09/28/09
Movers Roundup: VeriSign, Basic Energy Services
Movers roundup: VeriSign rises on Credit Suisse upgrade, Basic Energy Services stock climbs
02:52PM 08/12/09
Seattle Genetics Gains On Offering, Analyst View
Seattle Genetics shares rise as analyst starts coverage with 'Buy,' company raises $118M
12:48PM 08/12/09
This Week's 'Barron's' Roundup
A handful of stocks to short right now, plus some S&P 500 names that are getting into nosebleed territory.
05:39PM 07/04/09
Small-Cap Biotechs Pop Before Conference
Small-cap cancer drugs get a lift before the American Society of Clinical Oncology's annual meeting.
09:11AM 05/28/09



Connect with TheStreet